A kind of biodegradable pesticide sustained-release emulsifiable concentrate and its preparation method and application
A slow-release emulsifiable concentrate and pesticide technology, applied in the directions of botanical equipment and methods, applications, biocides, etc., can solve the problems of affecting the ecological environment, complex preparation methods, poor degradability, etc., and achieve simplified preparation methods, simple preparation methods, The effect of high production efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The embodiment of the present invention provides a kind of 5% emamectin b2a benzoate sustained-release emulsifiable concentrate, comprising the following components in mass percentage:
[0030] Emamectin b2a benzoate 5%, polylactic acid-glycolic acid copolymer 20%, sucrose fatty acid ester 1%, diacetyl tartaric acid mono-diglyceride 9%, stearic acid 0.33%, lipoic acid 0.67 %, ethylene glycol monoalkyl ether carboxylate 5.8%, and diethylene glycol monoethyl ether make up to 100%.
[0031] The above-mentioned components are mixed and stirred uniformly to prepare the 5% emamectin b2a benzoate sustained-release emulsifiable concentrate.
Embodiment 2
[0033] The embodiment of the present invention provides a kind of 10% emamectin b2a benzoate sustained-release emulsifiable concentrate, comprising the following components by mass percentage:
[0034] Emamectin b2a benzoate 10%, polylactic acid-glycolic acid copolymer 25%, sucrose fatty acid ester 3%, diacetyl tartaric acid mono-diglyceride 8%, stearic acid 0.25%, lipoic acid 0.75 %, ethylene glycol monoalkyl ether carboxylate 6%, diethylene glycol monoethyl ether make up to 100%.
[0035] The above-mentioned components are mixed and stirred evenly to prepare the 10% emamectin b2a benzoate slow-release emulsifiable concentrate.
Embodiment 3
[0037] The embodiment of the present invention provides a 15% emamectin b2a benzoate slow-release emulsifiable concentrate, comprising the following components in mass percentage:
[0038] Emamectin b2a benzoate 15%, poly(lactic-co-glycolic acid) 22.5%, sucrose fatty acid ester 7%, diacetyl tartaric acid mono-diglyceride 5%, stearic acid 0.3%, lipoic acid 1.2 %, ethylene glycol monoalkyl ether carboxylate 7%, diethylene glycol monoethyl ether to make up to 100%.
[0039] The above-mentioned components are mixed and stirred evenly to prepare the 15% emamectin b2a benzoate slow-release emulsifiable concentrate.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


